Remove Resources Facilities
article thumbnail

STAT+: FDA efforts to oversee foreign drug manufacturing remain inadequate to ensure safety, analysis finds

STAT

In the wake of the Covid-19 pandemic, the Food and Drug Administration inspected far fewer domestic and foreign pharmaceutical facilities, even though manufacturing activity did not decline, according to a new analysis. Europe, India, and China, although there was a slight pullback last year in India and China.

article thumbnail

Opinion: Hospital financing in black and white

STAT

The resources for patient care and comfort were sumptuous in some facilities, spartan in others. During our training as doctors, we have rotated through safety-net hospitals, elite academic medical centers, and private clinics. While the 1964 Civil Rights Act forbade hospitals from discriminating based on race, segregation persists.

Hospitals 239
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PharmaLogic launches new radiopharmaceutical facility in New York, US

Pharmaceutical Business Review

The Bronx facility is equipped with latest technology and marks a significant investment by PharmaLogic in the development of new radiopharmaceuticals in the region. The production and laboratory space featured at the facility is designed to enable PharmaLogic to scale up its existing production capabilities.

article thumbnail

3GV by Rx Propellant gains ‘IFC-EDGE Advanced’ sustainability certification

Express Pharma

Rx Propellant announces that 3GV, one of its pharma and life sciences facilities located at Genome Valley, Hyderabad, has secured the distinction of being the first ‘IFC-EDGE Advanced’ Certified Speculative Life Sciences Building, globally.

74
article thumbnail

The Definition of Patient Safety and Implementing Technologies (PDA/FDA Joint Regulatory Conference 2023)

PharmaTech

Maik Jornitz, Principal Consultant, BioProcess Resources LLC, discusses the definition of patient safety and how to implement new technologies into upgraded facilities.

98
article thumbnail

New manufacturing facility could drive gold standard in cell therapy

European Pharmaceutical Review

A new Denmark-based manufacturing facility is set to establish the final development steps and upscaling of cell therapies. Partly due to this and due to the explorative phase cell therapy is in, it is very expensive to develop and manufacture cell therapies, so there simply are not many facilities doing it.”

Hospitals 105
article thumbnail

Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development

Express Pharma

The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility spanning an area of 59,000 square feet (approximately 5,481 square meters) in Berlin. Operations at the newly built facility are planned to commence in late 2024.

98